Gross margin headwinds shadow ATH sales in Q2 Components and regulator capacity delay new portfolio Estimates cut 28-10%, trading at 12-8x EV/EBIT ’22-23e
Datapoints showing COVID-19 in the rearview mirror Russia sales ongoing but uncertain – EBIT est. down 10% ’21-’24e EBIT CAGR of 45% – ’22e EV/EBIT of 12x
Investment highlights provided by CEO Mr. Söderqvist Underlying progress to be visible when demand returns Entering an intriguing period of growth from H2’21